Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 24, 2012 16:05 ET | Source: Novavax, Inc.

NOVAVAX Provides Update on Influenza Programs

Primary Endpoints Achieved in Phase II Seasonal Influenza Trial Two H5N1 Pandemic Influenza Trials Fully Enrolled ROCKVILLE, Md., July 24, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc....
July 18, 2012 08:00 ET | Source: Novavax, Inc.

NOVAVAX and PATH Announce Partnership on RSV Vaccine

Novavax initially awarded approximately $2 million by PATH Potential for future PATH funding of 50% of external costs to develop maternal RSV vaccine available for low-resource...
July 16, 2012 08:00 ET | Source: Novavax, Inc.

NOVAVAX, CPL Biologicals and the International Centre for Genetic Engineering and Biotechnology Announce Collaboration to Develop New Malaria Vaccine With Funding From Government of India

ROCKVILLE, Md., July 16, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), CPL Biologicals (CPLB) and the International Centre for Genetic Engineering and Biotechnology (ICGEB), today announced...
July 05, 2012 09:02 ET | Source: Novavax, Inc.

NOVAVAX Reports on Progress with RSV Vaccine at New International Conference on Modern Vaccines

ROCKVILLE, Md., July 5, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) reported this week that Gregory Glenn, M.D., Senior Vice President and Chief Medical Officer of Novavax, reviewed recent...
June 27, 2012 08:00 ET | Source: Novavax, Inc.

Novavax to Review RSV Program at New International Conference on Modern Vaccines

ROCKVILLE, Md., June 27, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that Gregory Glenn, M.D., Senior Vice President and Chief Medical Officer of Novavax, will make a plenary...
June 04, 2012 08:00 ET | Source: Novavax, Inc.

NOVAVAX to Present at Jefferies 2012 Global Healthcare Conference

ROCKVILLE, Md., June 4, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company, announced today that Stanley C. Erck, President and Chief Executive Officer of Novavax,...
May 21, 2012 12:58 ET | Source: Novavax, Inc.

NOVAVAX, Inc. Announces $12 Million Equity Offering

ROCKVILLE, Md., May 21, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that on Friday, May 18, 2012, it sold 10,000,000 shares of its common stock to RA Capital Healthcare Fund,...
May 09, 2012 08:00 ET | Source: Novavax, Inc.

NOVAVAX Launches Additional Phase I Clinical Trial of A/H5N1 Influenza Vaccine Candidate

ROCKVILLE, Md., May 9, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that it has begun enrollment in a second Phase I clinical trial of its monovalent virus-like particle (VLP)...
May 04, 2012 08:00 ET | Source: Novavax, Inc.

NOVAVAX Reports First Quarter 2012 Financial Results

ROCKVILLE, Md., May 4, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced its financial results for the first quarter ended March 31, 2012. The company reported a net loss of $7.3...
May 02, 2012 08:00 ET | Source: Novavax, Inc.

NOVAVAX Launches Phase I Clinical Trial of A/H5N1 Influenza Vaccine Candidate

ROCKVILLE, Md., May 2, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that it has begun enrollment in a Phase I clinical trial of its monovalent virus-like particle (VLP) vaccine...